United States Uveal Melanoma Treatment Market Set to Soar with Breakthrough Therapies and Innovative Drug Developments 2025 | Top key players - Delcath Systems, Inc., Linnaeus Therapeutics, Inc., AstraZeneca Plc.

Market Overview:

The Global Uveal Melanoma Treatment Market is expected to reach at a Significant CAGR during the forecast period 2024-2031.

The Uveal Melanoma Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID): https://datamintelligence.com/download-sample/uveal-melanoma-treatment-market?sz

The Uveal Melanoma Treatment Market refers to the global industry focused on the development, manufacturing, and commercialization of therapies for uveal melanoma, a rare eye cancer affecting the uvea. It encompasses surgical procedures, radiotherapy, targeted therapies, and immunotherapies, driven by increasing disease awareness, technological advancements, and rising demand for effective, personalized treatment options worldwide.

Recent Key Developments of United States (U.S):

September 2025: A new clinical trial for Quisinostat was opened for patients with high-risk uveal melanoma to prevent metastasis after primary treatment.

September 2025: A key upcoming clinical trial was announced to test ipilimumab/nivolumab therapy after primary treatment to reduce the risk of recurrence.

August 2025 (late): Clinical trials for IDE196 (Darovasertib) + crizotinib combination therapy in HLA-A*02:01 negative metastatic uveal melanoma participants remained active and open for enrollment.

August 2025 (mid): A Phase 2/3 trial of RP2 (oncolytic virus) in combination with nivolumab versus nivolumab/ipilimumab in immune checkpoint inhibitor-naïve metastatic uveal melanoma patients was actively enrolling.

July 2025: Promising data from the OBX-115 TIL (engineered tumor-infiltrating lymphocyte) therapy in a Phase 1/2 trial for ICI-resistant melanoma (including uveal melanoma) was presented at a major medical conference.

List of the Key Players in the Uveal Melanoma Treatment Market:

Delcath Systems, Inc.
Immunocore, Ltd.
Eli Lilly and Company
iOnctura SA
Linnaeus Therapeutics, Inc.
AstraZeneca Plc.
IDEAYA Biosciences, Inc.
Verastem, Inc.
Foghorn Therapeutics
InxMed.

This Report Covers:

✔ Go-to-market Strategy.

✔ Neutral perspective on the market performance.

✔Development trends, competitive landscape analysis, supply side analysis, demand side analysis, year-on-year growth, competitive benchmarking, vendor identification, and other significant analysis, as well as development status.

✔Customized regional/country reports as per request and country level analysis.

✔ Potential & niche segments and regions exhibiting promising growth covered.

✔ Analysis of Market Size (historical and forecast), Total Addressable Market (TAM), Serviceable Available Market (SAM), Serviceable Obtainable Market (SOM), Market Growth, Technological Trends, Market Share, Market Dynamics, Competitive Landscape and Major Players (Innovators, Start-ups, Laggard, and Pioneer).

Looking For Full Report? Get it Here: https://www.datamintelligence.com/buy-now-page?report=uveal-melanoma-treatment-market

Segments Covered in the Uveal Melanoma Treatment Market:

By Disease Type: Choroid Melanoma, Iris Melanoma, Ciliary Melanoma.

By Treatment: Ruthenium Plaque Brachytherapy, Proton Beam Radiotherapy, Photodynamic Therapy, Thermotherapy (Heat Therapy), Surgery (Local Resection, Iridectomy, Enucleation, Exenteration, Eye Reconstructive Surgery), Immunotherapy (Tebentafusp), Others.

By End-User: Hospitals, Specialty Clinics, Radiotherapy Centers, Ambulatory Surgical Centers, Others.

Regional Analysis:

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/uveal-melanoma-treatment-market?sz

Chapter Outline

⏩ Market Overview: It contains five chapters, as well as information about the research scope, major manufacturers covered, market segments, Uveal Melanoma Treatment market segments, study objectives, and years considered.

⏩ Market Landscape: The competition in the Global Uveal Melanoma Treatment Market is evaluated here in terms of value, turnover, revenues, and market share by organization, as well as market rate, competitive landscape, and recent developments, transaction, growth, sale, and market shares of top companies.

⏩ Companies Profiles: The Global Uveal Melanoma Treatment market's leading players are studied based on sales, main products, gross profit margin, revenue, price, and growth production.

⏩ Market Outlook by Region: The report goes through gross margin, sales, income, supply, market share, CAGR, and market size by region in this segment. North America, Europe, Asia Pacific, Middle East & Africa, and South America are among the regions and countries studied in depth in this study.

⏩ Market Segments: It contains the deep research study which interprets how different end-user/application/type segments contribute to the Uveal Melanoma Treatment Market.

⏩ Market Forecast: Production Side: In this part of the report, the authors have focused on production and production value forecast, key producers forecast, and production and production value forecast by type.

⏩ Research Findings: This section of the report showcases the findings and analysis of the report.

⏩ Conclusion: This portion of the report is the last section of the report where the conclusion of the research study is provided.

Unlock 360° Market Intelligence with DataM Subscription Services: https://www.datamintelligence.com/reports-subscription

People Also Ask:

◆ How big is the Uveal Melanoma Treatment Market in 2025?
◆ What is the projected growth rate of the Uveal Melanoma Treatment Market through 2033?
◆ Who are the key players in the Uveal Melanoma Treatment Market?
◆ Which region is expected to dominate the industry during the forecast period?

Contact Us -
Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -
DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.
Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.